Morgan Stanley Lowers Ovintiv (NYSE:OVV) Price Target to $64.00
Ovintiv (NYSE:OVV – Get Rating) had its target price decreased by equities research analysts at Morgan Stanley from $65.00 to $64.00 in a note issued to investors on Tuesday, Stock Target Advisor reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 37.40% from the […]